HMX2

HMX2 is a homeodomain transcription factor that controls cell fate specification and morphogenesis in the inner ear and kidney collecting duct. HMX2 binds TAAT-containing DNA sequences with a paralog-distinct secondary binding specificity not shared with HMX3, and its targeted disruption in mice blocks vestibular morphogenesis by reducing otic epithelial cell proliferation and abolishing expression of downstream regulators Bmp4, Dlx5, and Pax2 (PMID:11748138, PMID:10543441). In the zebrafish otic vesicle, HMX2 acts cell-autonomously within a reciprocal FGF signaling feedback loop to specify mechanosensory organ cell fate, while cross-species knockin experiments demonstrate deep functional conservation of HMX2 from Drosophila to mammals (PMID:20043901, PMID:15363417). In the kidney collecting duct, HMX2 is required for type B intercalated cell differentiation through mutual transcriptional repression with Dmrt2; loss of Hmx2/Hmx3 converts B-intercalated cells to an A-intercalated cell program, and ectopic HMX2 expression silences Dmrt2 while activating the anion transporter Slc26a4 (PMID:40354537, PMID:41051882).

1. 1999 Medium

   Establishing that HMX2 is a sequence-specific DNA-binding protein with paralog-distinct target recognition addressed the fundamental question of whether HMX2 and HMX3 have biochemically distinguishable activities despite high homology.

   Evidence In vitro binding site selection (SELEX) with purified Nkx5-2 and Nkx5-1 proteins

   PMID:10543441

   Open questions at the time

   • In vitro binding specificity not validated with in vivo chromatin occupancy data
   • Functional significance of the novel non-TAAT binding site is unknown
   • No target genes identified through this binding specificity
2. 2001 High

   The first loss-of-function study established that Hmx2 is essential for vestibular morphogenesis, acting upstream of Bmp4, Dlx5, and Pax2 by controlling cell proliferation in the lateral otic epithelium — answering whether Hmx2 has a non-redundant developmental role.

   Evidence Targeted knockout mice with histological analysis and in situ hybridization for downstream markers in the otocyst

   PMID:11748138

   Open questions at the time

   • Direct transcriptional targets of HMX2 in the otic epithelium remain unidentified
   • Mechanism by which HMX2 promotes cell proliferation is unknown
   • Whether HMX2 directly regulates Bmp4/Dlx5/Pax2 promoters or acts indirectly is unresolved
3. 2004 High

   Cross-species knockin rescue and double-knockout analysis resolved the question of functional overlap between Hmx2 and Hmx3: the two paralogs are interchangeable for hypothalamic/pituitary development but non-redundant in the vestibular system, and Drosophila Hmx can substitute for vertebrate Hmx2, establishing deep evolutionary conservation.

   Evidence Drosophila Hmx knockin replacing murine Hmx2/Hmx3, double knockout analysis, histological phenotyping

   PMID:15363417

   Open questions at the time

   • Molecular basis for tissue-specific redundancy versus non-redundancy between HMX2 and HMX3 is unresolved
   • Which structural domains confer cross-species functional equivalence has not been mapped
4. 2010 High

   Demonstrating that FGF signaling activates hmx2 expression and that hmx2 in turn maintains FGF ligand expression established a reciprocal feedback loop, answering how hmx2 is integrated into upstream signaling during mechanosensory organ specification.

   Evidence Morpholino knockdown of hmx2/hmx3 in zebrafish combined with pharmacological FGF pathway inhibition and in situ hybridization for downstream markers

   PMID:20043901

   Open questions at the time

   • Whether HMX2 directly binds FGF ligand gene promoters is unknown
   • The identity of the specific FGF receptor mediating hmx2 activation has not been determined
   • Whether this feedback loop operates in mammalian inner ear development has not been tested
5. 2020 Medium

   Identification of HMX2 as a transcriptional target of IRF8, WNT, and NF-κB signaling in AML cells, and demonstration that HMX2 knockdown induces myeloid differentiation, revealed an unexpected role for HMX2 in maintaining an undifferentiated state in leukemia and connected upstream regulatory mutations to ectopic HMX2 activation.

   Evidence siRNA knockdown, reporter gene assays, expression profiling, and whole-genome sequencing in KMT2A-aberrant AML cell lines

   PMID:33048949

   Open questions at the time

   • Findings are from a single laboratory using cell lines; in vivo leukemia models have not been tested
   • Direct binding of HMX2 to target gene promoters (EPX, FIP1L1-PDGFRA, HTR7) has not been shown
   • Clinical relevance of HMX2 regulatory mutations in AML patients is unknown
6. 2025 High

   Two independent studies established that HMX2 and Dmrt2 form a mutually repressive transcriptional switch specifying type B versus type A intercalated cell identity in the kidney collecting duct, resolving a long-standing question about how IC subtype diversification is controlled and demonstrating a physiological role for HMX2 in acid-base homeostasis.

   Evidence CRISPR/Cas9 conditional single/double/triple knockouts, knockin alleles, ureteric organoid culture with ectopic expression, urine acidification assays, and single-cell RNA-seq in mouse and human kidney

   PMID:40354537 PMID:41051882

   Open questions at the time

   • Whether HMX2 directly binds the Dmrt2 and Slc26a4 promoters/enhancers has not been demonstrated by ChIP or similar assays
   • The upstream signal that initiates HMX2 versus Dmrt2 expression in IC precursors is unknown
   • Whether HMX2 mutations contribute to human distal renal tubular acidosis has not been investigated

• Genome-wide direct target identification (e.g., ChIP-seq) for HMX2 has not been performed in any tissue, leaving its full transcriptional program and the mechanism by which it activates or represses specific promoters unresolved.
• No ChIP-seq or CUT&RUN data exist for HMX2 in any system
• Cofactors and chromatin remodelers recruited by HMX2 are unknown
• Structural basis for HMX2's paralog-distinct DNA-binding specificity has not been determined